Call for abstracts and registration: 18 March, 2022
Abstracts submission deadline:
16 August, 2022 to 09 September, 2022
Abstracts presenters registration deadline: 22 September, 2022
Early fee registration deadline: 22 September, 2022
Late fee registration deadline: 19 October, 2022
General guidelines for abstracts submission
Abstracts received after the deadline will not be considered.
Submission of an abstract acknowledges your acceptance for its publication in the conference programme and online abstract supplement of the Cardiovascular Research Journal. If accepted, your abstract will be published as submitted.
The presenting author must be the contact author in the submission form and he/she must be listed the first in the list of authors. Please make sure you have enter the full list of authors and that the information given for each author is correct. The authors’ order and details will be published as entered by the submitter.
Each presenting author can submit a maximum of three (3) abstracts. The presenting author must have a fully paid registration for the EuroThrombosis & EuroVessels 2022 conference by 22 September, 2022 to ensure the abstract is scheduled for presentation and included in the programme and online abstract supplement.
Authors will be required to indicate whether oral or poster presentation is preferred and to select a topic. The final type of presentation and session will be determined by the conference scientific committee after the reviewing process.
The abstract submission deadline was postponed to 09 September, 2022.
The abstract presenters registration deadline is 22 September, 2022.
All abstract presenters must have a fully paid registration for the congress.
Title, type of presentation and topic
Special characters, symbols and super and sub-script are accepted following the next rule: type them in Word and copy-paste them into the title field.
Text of the abstract
Abstracts must not exceed 250 words and must be submitted in English. Please do not leave blank lines to separate paragraphs. Special characters, symbols, greek and mathematical symbols and super and sub-script are accepted following the next rule: type them in Word and copy-paste them into the text field.
Material and methods
Results and conclusions
Funding sources (if applicable)
The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission. Abstracts must be original and must not have been published or presented in the same form at any other meeting. Abstracts stating data will be discussed in the presentation or similar will not be accepted. The abstract body must not include any indication of the personal details of authors.
Evaluation and acceptance
The conference scientific committee reserves the right to reallocate abstracts in a different topic and to decide the final type of presentation. Authors will be notified by e-mail whether their abstract has been accepted or rejected. The final reference number and session assigned to each oral/poster will be notified by e-mail early September 2022.
Data privacy statement
The information collected is used to process the abstract submission, ensuring that you receive the information on abstract notification (acceptance/rejection) and that you receive a presentation certificate. Any personal data will be only used in accordance with the current EU data protection legislation (GDPR) and will not be disclosed to a third party without the delegate’s written consent to email@example.com.
The authors automatically authorise the Organisation to publish their abstracts in the book of abstracts and in any medical publishing that the Organisation might consider relevant.